HR 4709 · 113th Congress · Crime and Law Enforcement
Ensuring Patient Access and Effective Drug Enforcement Act of 2014
Bill Progress
✓
Introduced✓
Committee✓
House Vote4
Senate5
EnactedLatest: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2014-07-30)
Plain Language Summary
[AI summary unavailable — showing source text]
Ensuring Patient Access and Effective Drug Enforcement Act of 2014 - Amends the Controlled Substances Act to provide that: (1) a determination by the Attorney General that a registration to manufacture, distribute, or dispense a controlled substance is "consistent with the public health and safety" means that it has a substantial relationship to such Act's purpose of preventing diversion and abuse of controlled substances; and (2) a finding of "imminent danger" by the Attorney General justifying immediate suspension of such a registration means that there is a significant and present risk of death or serious bodily harm that is more likely than not to occur in the absence of such a suspension. Requires the Attorney General, before revoking or suspending a registration under such Act, to: (1) provide the registrant notice of the grounds for doing so, and where such grounds consist of a legal violation, a specific citation to such law; (2) give the registrant an opportunity to submit a corrective action plan within a reasonable time period; and (3) determine whether, in light of the plan, revocation or suspension proceedings should be discontinued or deferred or additional changes ne…
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeH.R. 4709, Ensuring Patient Access and Effective Drug Enforcement Act of 2014
Jul 8, 2014As ordered reported by the House Committee on Energy and Commerce on June 10, 2014
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office
Cosponsors (12)
2 Democrats10 Republicans